YAP1 and hepatocellular carcinoma: For example, the collaborative activation of CYR61 by YAP/TEAD4 and TGFβ/SMAD2/3 exerts a tumor‐suppressive effect in hepatocellular carcinoma, counteracting malignant transformation and growth [102].